Kinesin is the plus-end-directed microtubule motor: a motor domain that binds tubulin, hydrolyses ATP, and steps 8 nanometres at a time — hand-over-hand — hauling vesicles, organelles, and mRNA from the cell centre outward along microtubules. The founding kinesin-1 (KIF5) is a two-motor-two-light-chain tetramer walking processively for micrometres; the superfamily's ~45 human members run organelles, mitotic chromosomes, and cilia, and one member (kinesin-14) even walks the other way. Its axonal duties make it the long-haul trucker of neurons, where transport failure is neurodegeneration.
Gene
KIF family (~45 genes; KIF5B for ubiquitous kinesin-1)
The motor core is a P-loop NTPase fold — same superfamily as myosin — with a docking neck linker whose ATP-triggered zip delivers the power stroke.
Kinesin-1 is a KIF5B heavy-chain dimer plus two kinesin light chains that bind cargo adaptors; the stalk auto-inhibits by folding tail-to-motor until cargo activates it.
Members place the motor at N- (most), C- (kinesin-14, minus-directed), or internal positions (kinesin-13, depolymerisers) — one fold, three architectures.
Function
Anterograde transport: plus-end-out runs carry synaptic-vesicle precursors, mitochondria (via TRAK/Milton adaptors), and neurofilament cargo down axons — the outbound half of axonal logistics, with dynein on the return leg.
Mitosis: kinesin-5 (Eg5) slides spindle poles apart, kinesin-4 (chromokinesin) polarises chromosome arms, kinesin-13s depolymerise microtubule ends — the spindle's fleet of purpose-built trucks.
Cilia and secretion: kinesin-2 drives intraflagellar transport — the cilium's building supply line; kinesin-3 ferries secretory cargo to active zones.
Regulation
Autoinhibition (tail folds back onto the motor) releases only on cargo-adaptor binding — no freight, no fuel spent.
Phosphorylation (JNK, CDK, GSK3β) and cargo receptors tune recruitment; the MAP kinase path's axonal damage signalling down-regulates kinesin-based repair traffic.
Microtubule post-translational marks (acetylated, detyrosinated tubes) bias which tracks motors prefer — the tubulin-code reader side of the partnership.
Interactions
With tubulin rails and dynein's opposite lane, it defines bidirectional cargo logistics; myosin V hands off at the actin cortex.
Mitochondrial movement couples it to mitochondria's distribution — Miro/Milton calcium sensing stops the trucks where energy is needed.
Eg5 inhibition (monastrol, ispinesib) monopoles spindles — the mitotic kinesin drug class in trials.
Clinical Relevance
Neurology: KIF5A mutations — hereditary spastic paraplegia and CMT2 axonal neuropathies; KIF1Bβ — CMT2A; transport failure is a shared neurodegeneration mechanism (ALS models included).
Oncology: ispinesib and filanesib (KSP/kinesin-5 inhibitors) target mitosis without the myelosuppression of tubulin drugs; KIF11 and KIF15 expressions mark proliferative tumors.
Ciliopathies: KIF3A/B (kinesin-2) deletion dismantles primary cilia — the Hedgehog-signalling link, see sonic hedgehog.